Cytarabine (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Cytarabine drug offered from Fresenius Kabi USA, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: CYTARABINE
SUBSTANCE NAME: CYTARABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2004-11-29
END MARKETING DATE: 0000-00-00


Cytarabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCytarabine from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2004-11-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-120_6594799a-7b02-4847-aff7-1cb7842771bd
PRODUCT NDC: 63323-120
APPLICATION NUMBER: ANDA076512

Other CYTARABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCCytarabine
Hospira Worldwide, Inc.Cytarabine
Hospira, Inc.CYTARABINE
Mylan Institutional LLCCytarabine
Pfizer Laboratories Div Pfizer Inc.Cytarabine
Sigma-Tau Pharmaceuticals, Inc.DepoCyt